Press Releases
Abstract 651: Revealing the role of lung cancer microbiota in the tumor progression
Lung cancer (LC) remains as the leading cause of death by cancer worldwide. In Chile, LC is the second cause of cancer-related deaths. Recently, studies in melanoma and non-small cell lung cancer (NSCLC) patients have highlighted the role of the gut microbiota as an...
How the gut microbiome can help predict cancer immunotherapies
Transatlantic research group uncovers possible link between gut microbiota and cancer immunotherapy efficacy An international team of experts headed by Prof. Dr. Eran Elinav of the Cancer & Microbiome Division of the German Cancer Research Center (DKFZ), and led...
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial
Sixteen percent of cancers worldwide are attributable, at least in part, to infection, showing the link between microbial agents and tumorigenesis [1]. Studies to further investigate the role of the microbiome in cancer have accumulated in recent years, with a...
The Human Microbiota and Skin Cancer
The role of the human microbiota has recently been a focus of research interest in numerous cutaneous diseases including psoriasis and atopic dermatitis as well as skin cancer. The skin microbiota is increasingly thought to play an integral role in maintaining the...
Dysbiotic microbiome variation in colorectal cancer patients is linked to lifestyles and metabolic diseases
Differences in the composition and diversity of the gut microbial communities among individuals are influenced by environmental factors. However, there is limited research on factors affecting microbiome variation in colorectal cancer patients, who display lower...
NCI-funded project to study role of gut microbiome in prostate cancer
Christian Jobin, Ph.D., the Gatorade Trust Professor of Medicine in the division of gastroenterology, hepatology & nutrition in the University of Florida College of Medicine, and Raad Gharaibeh, Ph.D., a research assistant professor in the division, have received...
Healthy gut bacteria can help fight cancer in other parts of the body, UTSW researchers find
Researchers at UT Southwestern Medical Center have discovered how healthy bacteria can escape the intestine, travel to lymph nodes and cancerous tumors elsewhere in the body, and boost the effectiveness of certain immunotherapy drugs. The findings, published in...
Going big by going small: Trade-offs in microbiome explanations of cancer
Microbial factors have been implicated in cancer risk, disease progression, treatment and prevention. The key word, however, is “implicated.” Our aim in this paper is to map out some of the tensions between competing methods, goals, and standards of evidence in cancer...
Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
Accumulating evidence supports not only the functional role of the gut microbiome in cancer development and progression but also its role in defining the efficacy and toxicity of chemotherapeutic agents (5-fluorouracil, cyclophosphamide, irinotecan, oxaliplatin,...
